GENE ONLINE|News &
Opinion
Blog

Vaccine
Asia Microbiome Conference Highlights: COVID-19 Variants, New Strain Culturing, and Upcoming Trends
2021-01-28Partner
Moderna Applies Two-Pronged Strategy to Fight against Coronavirus Variants 
2021-01-26
Merck Withdraws from COVID-19 Vaccine Race Due to Sub-par Response
2021-01-25
COVID-19: Another Study Suggests Pfizer/BioNTech Vaccine is Capable of Neutralizing UK Variant
2021-01-20
Johnson & Johnson’s Single Dose COVID-19 Vaccine is Safe and Promising
2021-01-17
Philippines Signs Second Vaccine Deal to Procure 30 Million Doses of Novavax’s Covovax
2021-01-12
Battle Ground Brazil: What is the Country Doing to Curb Record COVID-19 Deaths?
2021-01-08
COVID-19: South Korea and Japan Make New Plans to Fight the Pandemic
2021-01-08
Arcturus’ COVID Vaccine Moves to Phase 2 Trial in Singapore
2021-01-05
AstraZeneca, Bharat Biotech Vaccines Nab Emergency Approval in India
2021-01-04
Pick your Potion, An Overview of the COVID Vaccines
2020-12-31
COVID-19: Oxford/AstraZeneca’s DNA Vaccine Scores Emergency Use Approval in the UK
2020-12-30
New COVID-19 Variant: Vaccine Makers Optimistic but Experts are Cautious over Unique Mutations
2020-12-24
Moderna’s COVID-19 Vaccine Bags FDA’s Emergency Use Authorization, Inoculations to Start on Monday
2020-12-19
FDA Panel Recommends Moderna’s COVID-19 Vaccine for Emergency Use Authorization
2020-12-17
1 4 5 6 7 8 10
LATEST
Biotech in Beauty: Engineered Skin Bacteria Designed To Treat Acne
2024-05-10
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
EVENT
Scroll to Top